Vectorite Biomedical Stock

Vectorite Biomedical Operating Expenses

The Total Operating Expenses of Vectorite Biomedical (4170.TWO) as of Aug 22, 2026 is 43.59 M TWD. In the previous year, Total Operating Expenses was 39.50 M TWD — a change of 10.37% (higher).

Operating Expenses

43.59 MTWD

YoY

10.37%

Last updated:

Total Operating Expenses of Vectorite Biomedical is 2026 43.59 M TWD. Total Operating Expenses of Vectorite Biomedical was 2025 39.50 M TWD. It decreases by 10.37% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Total Operating Expenses of Vectorite Biomedical is 43.59 M TWD in 2026.

Total Operating Expenses of Vectorite Biomedical changed from 39.50 M TWD to 43.59 M TWD, representing a 10.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Vectorite Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Vectorite Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vectorite Biomedical